Peter Sarosi Hungarian Civil Liberties Union (HCLU) Dialogoue on Drug Policy 8 June, 2006. European and Hungarian drug policies: based on evidence?

Slides:



Advertisements
Similar presentations
TREATMENT DATA INDICATORS IN THE UNODC DATA COLLECTION SYSTEM.
Advertisements

Women in treatment in the Czech Republic Běla Studničková, M. D., Vladimír Polanecký, M. D. Drug Epidemiology Headquarters Hygienic Station of the Capital.
HIV in Europe Stockholm, 3.November 2009 Communication on combating HIV/AIDS in the EU and the neighbourhood - strategy and second action plan ( )
Krzysztof Krajewski Jagiellonian University Department of Criminology Krakow - Poland Gaps in the knowledge base – evidence in the criminal justice system.
Local Pass Conference Innovative Local Approaches towards New Trends in Psychoactive Substance Use “Time to Rethink our Policy on Drugs - Effective Drug.
2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.
Experiences of Drug Consumption Rooms in Europe
Llad Phillips 1 Casual Users, Substance Abusers, and Public Policy The War On Drugs.
Supporting community action on AIDS in developing countries MDG’s and the Law: Creating an Enabling Legislative Environment Anton Kerr Head of Policy –
“Humanitarian Action” The Saint-Petersburg Charitable Foundation for Medical and Social Programs HAF.
Presentation ‘Developing positive working relationships between Health and Law Enforcement Agencies’
People left behind: People living with HIV
1 Description of the addiction service of the Republic of Uzbekistan Jur’at Umargaliev Ministry of Health.
Llad Phillips 1 Casual Users, Substance Abusers, and Public Policy The War On Drugs.
THE NEED FOR HARM REDUCTION THE SITUATION IN BULGARIA Bulgarian DU Activism Milena Naydenova – Hope-Sofia.
A Health Based Approach Within The UN Conventions: Examples Of Practice Fay Watson, Vice Chair: EU Civil Society Forum on Drugs.
Decriminalization of Drugs in Portugal: Lessons for Public Health Kellen Russoniello, JD, MPH Health Policy Fellow, ACLU of San Diego & Imperial Counties.
ESPAD – are young Europeans getting more alike? Björn Hibell EMCDDA Conference Identifying Europe's Information needs for effective drug.
Information needs for effective drug policy in the programme of the CZ PRES Identifying Europe’s information needs for effective drug policy Lisbon /
How to survive in a non-supportive environment: Experience from Russia Ivan Varentsov (Andrey Rylkov Foundation) AIDS 2014, Melbourne.
The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.
HIV and drug prevention in Estonia Harm reduction services
An EMCDDA view on recovery Roland Simon Head of Unit Intervention, Best Practice, and Scientific Partners.
Municipal Drug Policy Legislation, institutions and programs Assoc. Prof. Hristo Bozov, MD, PhD Deputy-Mayor of Municipality of Varna Chairman of Municipal.
Encuentro de Líderes Latinoamericanos con la Federación Mundial Contra Las Drogas MIÉRCOLES 3 DE DICIEMBRE DE 2014, BUENOS AIRES Sven-Olov Carlsson, International.
Effective Drugs Policy and Harm Reduction in Tanzania
Harm Reduction.
Soft Drugs in Amsterdam 英三 1 24 th Dec Summary Proponents of legalizing drugs should be legalized. They suggest that “soft” drugs, such as marijuana,
HARM REDUCTION RESPONSES TO DRUGS IN THE EUROPEAN UNION – FROM MARGIN TO MAINSTREAM 8 th Annual Meeting of the European Red Cross / Red Crescent Network.
Annual report 2010: the state of the drugs problem in Europe.
Annual report 2009: the state of the drugs problem in Europe International Conference: New trends in drug use: facts and solutions, Parliament of the Republic.
Overview of Drug Control in Foreign Countries. Drug Control in EU A. Policy Trends ■ Decriminalisation of possession of small amount of drugs for personal.
An overview of European trends and developments Roland Simon ECAD Meeting 2011, Varna.
Changes in drug policies in the Netherlands and their impact on drug markets Marianne van Ooyen-Houben Edward Kleemans ESC Porto September 2015.
Drug Policy: Prohibition, Decriminalization, Legalization.
Washington D.C., USA, July 2012www.aids2012.org Human rights as a key component of harm reduction strategy targeting people using drugs in Morocco.
Twinning Project Implementation of Strategy for Fight Against Drugs in Serbia Kick off and Assessment November 2012 Belgrade.
2008 Minnesota HIV/AIDS Surveillance Report - Key Trends Lorraine Teel- Executive Director.
Australia’s Drug Policy Greg Denham Nossal Institute for Global Health.
Police DRUG POLICY And PROGRAMS. Harm Minimisation Supply Reduction Demand Reduction Harm Reduction.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
What can we learn from the Portuguese decriminalization of illicit drugs? Dr Caitlin Hughes Drug Policy Modelling Program NDARC, The University of New.
Dr Ashley Brown Consultant Hepatologist, St. Mary’s and Hammersmith Hospitals, London and Honorary Senior Lecturer, Imperial College London The Updated.
Lydia H. Guterman Consultant, Open Society Institute September 25, 2008 Sofia, Bulgaria Many thanks to the Harm Reduction Coalition for partial content.
Linda Montanari, Buenos Aires, October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting The Information System on Treatment Demand in EU EMCDDA.
Methods Data for this NIDA-funded HIV prevention trial (Project WORTH) were drawn from 337 women offenders under community supervision, who reported using.
EU model – evidence based Out of 100% of people who tried drugs, only 10% get to chronicle stage Out of 100% of people who tried drugs, only 10% get to.
„ Roma and Drugs in Figures – the Czech Republic“ Budapest, October 2004 Czech National Focal Point for Drugs and Drug Addiction Office of the Government.
A tale of two drug policies: Portugal and Sweden Alex Stevens, PhD Professor in Criminal Justice.
School of Public Health and Community Medicine How policies and repressive law- enforcement fuel the HIV epidemic among people who inject drugs Professor.
Regional Videoconference Addressing Stigma and Discrimination of HIV/AIDS in Africa Thursday, April 2, 2009 UNAIDS Perspective Susan Timberlake, Senior.
Overview of EMCDDA’s 2009 Scientific Work Programme Paul Griffiths, Roland Simon - REITOX Meeting, Lisbon, November 2007.
What is the situation in Portugal 14 years after the reformof the drug policy Rita Faria Jorge Quintas School of Criminology – Faculty of Law of the University.
1 Background & history of the debate Geneva, 14 October 2009 Ralf Jürgens.
Evaluating screening and brief intervention in a criminal justice setting Adrian Barton & Greta Squire School of Law and Social Science University of Plymouth.
Social rehabilitation and reintegration of drug addicts in community – experience from EU Dr. Josef Radimecký, Ph.D., MSc. UN International Day against.
FIDUCIA New European Crimes and Trust-based Policy OVERCRIMINALIZATION AND PRISON OVERCROWDING: RECENT FINDINGS FROM THE FIDUCIA PROJECT IN THE FIELD OF.
From evidence to commitment to action: implementing HIV prevention measures in prisons in Ukraine XVI International AIDS Conference Toronto, 15 August.
‘Global trends in decriminalisation: A quiet revolution ’ 2.0 Niamh Eastwood Release 16 May 2016.
PREVENTION OF DRUG ABUSE AMONG VULNERABLE GROUPS Dr Marcus Roberts Director of Policy and Membership DRUGSCOPE.
‘The War on Drugs: Failures, Impacts, and Alternatives, and the Future of Public Health’ Niamh Eastwood Release 15 November 2014.
Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.
Briefing to Member States Information under embargo
Alcohol and Drug Problem in Poland. Implications for policy Janusz Sierosławski Institute of Psychiatry i Neurology 3rd Meeting of the Expert Group on.
The Aviator Hotel – South Africa Uganda Harm Reduction Network (UHRN)
Harm reduction: decriminalising drug use in Asia
Henry L. Dorkin, MD, FAAP President, Massachusetts Medical Society
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Legalization of Drugs The Dutch experience.
Beyond drug criminalisation: Why, what and how?
Presentation transcript:

Peter Sarosi Hungarian Civil Liberties Union (HCLU) Dialogoue on Drug Policy 8 June, European and Hungarian drug policies: based on evidence?

Legal aid service for vulnerable populations (drug users, PLWHA, psychiatric patients). Since 1994 HCLU attorneys have assisted over 4,000 clients (individual and NGO). Legal aid service for vulnerable populations (drug users, PLWHA, psychiatric patients). Since 1994 HCLU attorneys have assisted over 4,000 clients (individual and NGO). Impact litigation (improving legislation through lawsuits) and harm reduction advocacy Impact litigation (improving legislation through lawsuits) and harm reduction advocacy Trainings, conferences, publications Trainings, conferences, publications

EU drug policies are often contrasted with U.S. drug policy as an example of a „balanced”, „integrated” and „science based” approach: 1. Proper balance between law enforcement and public health interventions 2. Interventations are the results of a strategic, integrated approach to drug problems 3. Measures taken by governments are based on scientific evidence Is this a dream or reality?

Aims of the EU Drug Strategy ( ) 1. to reduce significantly over five years the prevalence of drug use, as well as new recruitment to it, particularly among young users under 18 years of age 2. to reduce substantially over five years the incidence of drug-related health damage (HIV, hepatitis, TBC etc.) and the number of drug-related deaths 3. to increase substantially the number of successfully treated addicts 4. to reduce substantially over five years the availability of illicit drugs 5. to reduce substantially over five years the number of drug- related crimes 6. to reduce substantially over five years money-laundering and the illicit trafficking of precursors

Evaluation of drug strategy by EMCDDA, No decrease in life prevalence, in some countries there is an increase 2. Slight decrease in drug related deaths, stabilizing HIV/AIDS situation 3. There is an increase in treatment demand – no data on the success rate 4. Quantity of seized drugs increased, no decrease in access to drugs 5. Drug related crime is growing 6. No decrease in precursor trafficking, number of money laundering transactions is on the rise

Conclusions Interventions aimed to eliminate or significantly reduce drug phenomenon as such doomed to be a failure → no reduction in supply or in demand Interventions aimed to eliminate or significantly reduce drug phenomenon as such doomed to be a failure → no reduction in supply or in demand Public health and social interventions to reduce problem drug use and other related harms are succesful → treatment and harm reduction Public health and social interventions to reduce problem drug use and other related harms are succesful → treatment and harm reduction DRUGS ARE HERE TO STAY – BUT THE HARMS OF DRUG USE CAN BE PREVENTED AND TREATED

Member states and the European Commission ignored the findings of the EMCDDA No scientific forum or public discussion on the previous strategy to find alternatives No scientific forum or public discussion on the previous strategy to find alternatives No involvment of civil society in the preparation of the new drug strategy No involvment of civil society in the preparation of the new drug strategy The new drug strategy ( ) is based on the same principles as the previous: The new drug strategy ( ) is based on the same principles as the previous: 1) main goal is to eliminate or significantly reduce drug phenomenon 2) Social and public health interventions (2 pages) are subordinated to law enforcement interventions (5 pages) IS EU DRUG POLICY AS SUCH BASED ON SCIENCE?

There is no consensus on drug policy in European level → if we want to find best practices for science based interventions we have to search them in national/local level MAIN TRENDS: Social and public health policies becoming more important in most countries Social and public health policies becoming more important in most countries Legislation tends to decriminalize drug possession and focus on supply reduction Legislation tends to decriminalize drug possession and focus on supply reduction Some cities are experimenting with innovative ways to provide access to illicit drugs Some cities are experimenting with innovative ways to provide access to illicit drugs THERE IS A CONTRAST BETWEEN PROGRESSIVE LOCAL DRUG POLICIES AND UN/EU DRUG POLICIES

Examples of best practices Best practice #1: heroin maintenance (Switzerland, Netherlands, Germany, Spain) → both clients and society experienced significant benefits (e.g. reduced number of mortality and morbidity, crime and unemployment, housing problems etc.) (Uchtenhagen, 1997; Jürgen Rehm at al, 2001) Best practice #2: pill testing (Austria, Germany, Spain etc.) → best contact with party goers, prevention of accidents and infections, monitoring illicit drug markets (EMCDDA report, 2001) Best practice #3: supervised injection sites (Germany, Netherlands, Spain) → reduction of blood born infections, ODs and street drug use (EMCDDA report, 2004)

According to scientific evidence repressive drug policies do not result less drug use than lenient drug policies

However, there is a difference in the impacts of different drug policies on problem drug use Prevalence of drug use is higher in the Netherlands than in Sweden, but the prevalence of problem drug use is almost double in Sweden (4 per ), where injecting drug use and related health problems are on the rise Prevalence of drug use is higher in the Netherlands than in Sweden, but the prevalence of problem drug use is almost double in Sweden (4 per ), where injecting drug use and related health problems are on the rise There is a signficant difference in the quality of life and health of drug users in countries with different drug policies There is a signficant difference in the quality of life and health of drug users in countries with different drug policies Less repressive drug policies result in less public health and social damage related to drug use/trafficking Less repressive drug policies result in less public health and social damage related to drug use/trafficking

COMPARISON OF SOME SUCCESS INDICATORS OF U.S. AND DUTCH DRUG POLICIES Lifetime prevalence of marijuana use (ages 12+) 2001 US: 36.9% Netherlands: 17.0% Lifetime prevalence of marijuana use (ages 12+) 2001 US: 36.9% Netherlands: 17.0% Past month prevalence of marijuana use (ages 12+) 2001 US: 5.4% Netherlands: 3.0% Past month prevalence of marijuana use (ages 12+) 2001 US: 5.4% Netherlands: 3.0% Lifetime prevalence of heroin use (ages 12+) 2001 Lifetime prevalence of heroin use (ages 12+) 2001 US: 1.4% Netherlands: 0.4% Incarceration Rate per 100,000 population 2002 Incarceration Rate per 100,000 population 2002 US: 701 Netherlands: 100 Per capita spending on criminal justice system (in €) 1998 US: €379 Netherlands: €223 Per capita spending on criminal justice system (in €) 1998 US: €379 Netherlands: €223 Homicide rate per 100,000 population Average US: 5.56 Netherlands: 1.51 Homicide rate per 100,000 population Average US: 5.56 Netherlands: 1.51

There are major differences between the drug policies of Central-Eastern Europe (except Slovenia and Czech Republic) and Western Europe The legislation is more repressive in new member states The legislation is more repressive in new member states Less resources and appreciation for public health policies Less resources and appreciation for public health policies Limited access to social and health care for drug users Limited access to social and health care for drug users Greater risks of problem drug use (morbidity, mortality) Greater risks of problem drug use (morbidity, mortality) Moralistic and not pragmatic approach to drug users Moralistic and not pragmatic approach to drug users

WHO ARE THE PEOPLE WE ARE CRIMINALIZING? 91% of offenders were simple users – only 6-8% of offences are linked to significant amount of drugs 91% of offenders were simple users – only 6-8% of offences are linked to significant amount of drugs 97% of offenders are less than 30 y.o. 97% of offenders are less than 30 y.o. 70% has no previous criminal record 70% has no previous criminal record Every sixth offender is under 18 Every sixth offender is under 18 Drug offenders are the most educated group among all offenders Drug offenders are the most educated group among all offenders THE PRIZE OF RESTRICTIVE DRUG POLICIES: 1) Thousands of otherwise law abiding citizens conflict with the law (non-problematic users) 2) Limited access to social and health care for problem users

„Worst practices” from Hungary Police raids against dance clubs → hundreds of young people searched and arrested, few drugs seized, no dealers caught Police raids against dance clubs → hundreds of young people searched and arrested, few drugs seized, no dealers caught Police searches against clients of needle exchange programs → according to the Prosecutor General needle exchange is a crime Police searches against clients of needle exchange programs → according to the Prosecutor General needle exchange is a crime Alternative treatment → thousands of non-problematic drug users are refered to treatment programs by the criminal justice system while the budget for life saving services is very limited Alternative treatment → thousands of non-problematic drug users are refered to treatment programs by the criminal justice system while the budget for life saving services is very limited COSTS/RISKS > BENEFITS BAD ALLOCATION OF RESOURCES VIOLATION OF HUMAN RIGHTS

CONCLUSIONS European drug policies are far from being evidence based, but comparing with U.S. drug policy there is a significant progress, especially in the local level European drug policies are far from being evidence based, but comparing with U.S. drug policy there is a significant progress, especially in the local level The balance between law enforcement and public health is still not appropriate – limited access to services, violation of human rights of drug users The balance between law enforcement and public health is still not appropriate – limited access to services, violation of human rights of drug users The need for progress is especially urgent in Central-Eastern Europe → decriminalization of drug use can lead to better allocation of resources and more focus on (voluntary!) prevention, treatment and harm reduction The need for progress is especially urgent in Central-Eastern Europe → decriminalization of drug use can lead to better allocation of resources and more focus on (voluntary!) prevention, treatment and harm reduction

THANK YOU FOR YOUR ATTENTION! More info: